phm4153 cream formulation

35
Cream Formulation Kausar Ahmad Kulliyyah of Pharmacy http://staff.iiu.edu.my/akausar/PHM4153

Upload: jean-carla-rosario

Post on 21-Jun-2015

682 views

Category:

Documents


4 download

DESCRIPTION

cream formulation

TRANSCRIPT

Page 1: PHM4153 Cream Formulation

Cream Formulation

Kausar AhmadKulliyyah of Pharmacy

http://staff.iiu.edu.my/akausar/PHM4153

Page 2: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Contents

Ideal formulation

Types of excipients

Functions

Factors for consideration

Page 3: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Every medicinal product is a combination of the

drug substance and excipients.

Knowledge of the composition, function, and

behavior of excipients is a prerequisite to the

successful design, development and

manufacture of pharmaceutical dosage forms.

Page 4: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Formulation

Process whereby drugs are combined with other substances (excipients)

BindersFillersPreservatives etc.

to produce dosage formsOral (liquid, solid)Parenteral (IV, aqueous or oily injections)Rectal (suppositories, aerosols)Topical (cream, ointment, lotion)

suitable for administration to or by patients.

Page 5: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Excipients

Other components other than ACTIVE

ingredient/s intentionally added

to…….formulation

Page 6: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Ideal formulation

Non-irritant

Non-allergenic

Non-staining

Easy to apply

Pleasant feeling to

the skin

Non-toxic

Non-harmful

Incapable of microorganism growth

Free from side-effects

Page 7: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Requirement of formulation efficacy, safety, and quality

Contain an accurate dose Be convenient to take or administer Provide the drug in a form for absorption or other

delivery to the target Retain quality throughout the shelf life and usage

period Be manufactured by a process that does not

compromise performance and that is reproducible and economical

Page 8: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Factors to be considered in formulation

Physicochemical properties

Choice of vehicle

Waxes and oils or emulsions

Categories of excipients

Provide essential part of the dosage form

Prevent degradation of the formulation

Stability

Page 9: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Physicochemical Properties

Oils susceptible to oxidation

Incorporate antioxidants

E.g. BHT, BHA

Aqueous solutions support microbial growth

Incorporate water-soluble preservatives

E.g. methyl and propyl paraben

BUT these may affect the endocrine…..

Page 10: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Examples of Creams Whitening

Benzophenone, Hydroquinone Herbal-based (fair & lovely) Pearl Fruit extracts (olay, estee)

Anti-ageing Collagen, seaweed extract (Imedeen) liposome

Virility Active: fish & herbs (2 types) Excipients: aromatic emollient, Vitamin E, D-

panthenol

Page 11: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Bases for Creams

Bases from mixtures of low and high

MW PEG

Liposomes

Microemulsions

Multiple emulsions

Fluorocarbon emulsions – ultra low i

Page 12: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Functions of excipients

Aid processing during manufacturing

Protect, support, or enhance stability and

bioavailability

Assist product identification colour

Improve effectiveness and safety of product

during storage or use

QExample?

Page 13: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Choice of excipients

physiological inertness

physical and chemical stability

conformance to regulatory agency requirements

no interference with drug bioavailability

absence of pathogenic microbial organisms

commercially available at low cost

Page 14: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Limitation in choice of excipients

no single excipient would satisfy all the criteria;

therefore, a compromise of the different

requirements has to be made.

For example, although widely used in pharmaceutical tablet

and capsule formulations as a diluent, lactose may not be

suitable for patients who lack the intestinal enzyme lactase

to break down the sugar, thus leading to the gastrointestinal

tract symptoms such as cramps and diarrhea.

Page 15: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Categories of excipients Provide essential parts of dosage form

Emulsifiers

Suspending agents

Gelling agents

Binders

Prevent degradation of the formulationAnti-oxidants

Anti-bacterials

Preservatives

UV absorbers

Page 16: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Excipients in CREAMS

Bases….. SAA

Anionic - SDSNon-ionic – Span,

Tween Anti-oxidants – BHA, BHT Preservatives: methyl and

propyl paraben (potency, integrity, prevent microbial growth)

Stearic acid

Stearyl alcohol, cetyl

alcohol

Glycerol monostearate

Lanolin

Glycerin

Zinc stearate

opacifying agent,

dusting powder…..

Page 17: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Microstructural properties of creams

texture and consistency is determined by the phase

behaviour of the component emulsifiers.

Rheological, thermal and microscopical means

characterise the physico-chemical properties

X-ray diffraction data

Page 18: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Effect of carrier on drug delivery

Must not interact with active substance

Control rate of release from vehicle…

What are the delivery systems?

Alter stratum corneum resistance……

Physical? Chemical?

Enhance stratum corneum hydration…..

Page 19: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Delivery systems (in cosmetics)

Vesicular

liposomes & niosomes

Molecular

cyclodextrin

Particulate

Microcapsules, matrix

particles

Encapsulation

Why?

Page 20: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Excipients as Penetration enhancers

Increase delivery of active substance

1. Disturb packing of SC lipid bilayers…..

Examples: Sulfoxides, alcohols, polyols, alkanes, esters,

amines/amides of fatty acids, terpenes, surfactants,

cyclodextrins

2. disruption of skin barrier

Extraction of skin lipids with apolar solvents e.g. acetone

Physical stripping

Physically or chemically induced irritation

Page 21: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Effect of type of preparationAbsorption of retinyl palmitate

18% absorbed from acetone vehicle

compared to only

4% absorbed from o/w emulsion

Q What is the mechanism of absorption?

Page 22: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Excipients for hydration

Hygroscopic effect of NaCl, sorbitol,

polypropylene glycol, glycerol

Low MW glycerols alter water-binding capacity

of corneocytes

Urea not for < 5 years old

Gives moisturising effect

Page 23: PHM4153 Cream Formulation

Types

PHM4153 Dosage Design 2 2009/10

Page 24: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Page 25: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Physical and chemical propertiesof excipients

solubility

hygroscopicity

swelling

hydration capacity

particle size distribution

bulk density, tap density

specific surface area

complexation

infrared spectrum

microbes

Page 26: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Polyamide – an excipient

Carrier for insoluble ingredientsProtector for sensitive ingredientsSlow delivery & long lasting effect

10 m, porous 7 m, empty spheres

20 m

Page 27: PHM4153 Cream Formulation

Pore volume distribution of porous polyamide particles

PHM4153 Dosage Design 2 2009/10

Page 28: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Incompatibility

PhysicalImmiscibilit

y

insolubility

ChemicalpH effects – dissociation?

pH and disperse systems

Soap emulsions and polyvalent

cations

Complexation

Cationic and anionic

compounds of high MW

Reducing agents (cause fading

of dyes)

Page 29: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Drug type and pH of medium

pHbasic

acidic

neutral

DrugPromethazine

Chlorhexidine

Ibuprofen

Fentiazac

Piroxicam

Fluorouracil

Crotamiton

Hydrocortisone acetate

Page 30: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Incompatibility

Formulation and packaging materials

E.g. softening of plastic containers by methyl

salicylate ointment.

Q What reaction occurs?

Page 31: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Detection of Incompatibility

Cracked cream

Hydrolysis or oxidation ….visual..?

Discoloration

Precipitation

Page 32: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Emulsifying Wax BP

Incorporation of anionic emulgent resulted

in the following:

Crack

Hinder release of cationic medicaments

Lower the antimicrobial activity of a cationic

medicament or preservative.

Page 33: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Cationic compounds

1. Tertiary ammonium compounds Cetrimide

Cetylpyridinium chloride

Benzalkonium salts

Domiphen bromide

2. Chlorhexidine salts

3. Dequalinium salts

4. Acridines

5. Triphenylmethane dyes

6. Neomycin sulphate

Page 34: PHM4153 Cream Formulation

PHM4153 Dosage Design 2 2009/10

Exercise: Determine functions of excipients

Nizoral cream Ketoconazole PPG Steary alcohol Cetyl alcohol Sorbitan stearate Polysorbate Isopropyl myristate Sodium sulfite Purified water

Elomet cream 0.1% Mometasone furoate White petrolatum White wax PPG stearate Stearyl alcohol Ceteareth-20 Hexylene glycol Titanium dioxide Al starch octenylsuccinate Purified water Phosphoric acid - pH